University of Minnesota. Driven to Discover.
Steeply dropping cases, though, may cause the NIAID to vary from the original trial design.
A clinical trial of 2 Ebola vaccine candidates was launched today near Liberia's capital, but falling case numbers may pose problems.
The first batch of an experimental Ebola vaccine landed today in an outbreak country, with officials projecting a trial launch in Liberia within weeks.
The authors say the findings have proved useful in creating a more potent version.
Several early vaccine trials are under way, and another American is airlifted home.
Study results showed a good immune response at a high dose.
The small biotech and the drug giant announced an agreement today.
The end of the state of emergency called in August signals a shift in the fight against the virus.
The move comes a day after the DHS said travelers from outbreak nations would be funneled through 5 airports.
Hospital executive faced tough questions from Congress about speed bumps in the response to the quickly evolving Ebola situation.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.